Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cui Keliang
Observed names:
CUI Keliang,
Keliang Cui
Institutions:
Tianjin Medical University Cancer Institute and Hospital,
Tianjin Medical University
Observed institutions:
Tianjin Medical University Cancer Institute and Hospital,
Tianjin Medical University
ORCID:
0000-0001-5367-6459
Observed ORCID:
0000-0001-5367-6459
OpenAlex ID:
A5004913967
Low-incidence adverse events (AEs): An emerging challenge in chimeric antigen receptor T-cell (CAR-T) therapy
2026
·
Bingxue Li
, Keliang Cui
·
Cancer Pathogenesis and Therapy
·
1
PDF
Expert Consensus on Blood Flow and Oxygen Delivery Phenotyping and Clinical Management of Septic Shock(2025)
2026
·
HUANG Wei
, WANG Xinchen
, et al.
·
DOAJ (DOAJ: Directory of Open Access Journals)
Toripalimab-Induced Hemophagocytic Lymphohistiocytosis in a Patient with Breast Cancer: A Case Report
2026
·
JIA Xiaohui
, CUI Keliang
·
DOAJ (DOAJ: Directory of Open Access Journals)
Show more works
View as search
Works count:
3
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type